BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.1922
+0.0033 (1.75%)
At close: May 15, 2026, 4:00 PM EDT
0.1978
+0.0056 (2.91%)
After-hours: May 15, 2026, 6:58 PM EDT

BioRestorative Therapies Revenue

BioRestorative Therapies had revenue of $23.17K in the quarter ending March 31, 2026, a decrease of -7.32%. This brings the company's revenue in the last twelve months to $357.87K, down -8.47% year-over-year. In the year 2025, BioRestorative Therapies had annual revenue of $359.70K, down -10.30%.

Revenue (ttm)
$357.87K
Revenue Growth
-8.47%
P/S Ratio
13.68
Revenue / Employee
$25,562
Employees
14
Market Cap
4.90M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025359.70K-41.30K-10.30%
Dec 31, 2024401.00K255.20K175.03%
Dec 31, 2023145.80K26.00K21.70%
Dec 31, 2022119.80K73.80K160.43%
Dec 31, 202146.00K-31.00K-40.26%
Dec 31, 202077.00K-53.00K-40.77%
Dec 31, 2019130.00K19.00K17.12%
Dec 31, 2018111.00K30.00K37.04%
Dec 31, 201781.00K44.65K122.80%
Dec 31, 201636.36K-592.56K-94.22%
Dec 31, 2015628.92K212.92K51.18%
Dec 31, 2014416.00K414.32K24,661.67%
Dec 31, 20131.68K-13.91K-89.22%
Dec 31, 201215.59K--
Dec 31, 2011---
Dec 31, 2010---